School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Australia.
Pharmacy Department, Gold Coast Hospital and Health Service, Southport, Australia.
Support Care Cancer. 2022 Apr;30(4):3057-3072. doi: 10.1007/s00520-021-06679-8. Epub 2021 Nov 10.
This literature review examines the provision of an education on pharmacologically active complementary and alternative medicines (CAMs), to people with cancer, their carers and oncology health professionals.
A search of the published literature between 2000 and 2020, in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, was conducted. The search retrieved 1121 studies, 1080 were excluded based on their title or abstract and 26 articles were excluded based on their text. One article was retrieved from the reference lists of the included articles and in total fifteen studies met the inclusion criteria. This review utilised Medical Education Research Quality Instrument (MERSQI) to evaluate the quality of the included studies. Four key outcomes were utilised for analysis and recommendations for future education and/or research were generated. The recommendations were graded according to the Strength of Recommendation Taxonomy (SORT).
This review consistently found that people with cancer, their carers and oncology health professionals derived benefit from a pharmacologically active CAM education and recommends that this population receives one. Conversely, the review found many education formats utilised and no consensus on the most successful methods.
Future research should examine who a CAM education should be delivered to, what type of delivery platform is most accessible and useful, and the features of the education that most increase CAM knowledge. The popularity of CAMs amongst people with cancer and the potential dangers associated with their use necessitates further research into how best to communicate CAMs to this population.
本文献综述考察了为癌症患者、照护者和肿瘤学专业医疗人员提供关于具有药理活性的补充和替代医学(CAM)的教育。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,对 2000 年至 2020 年期间发表的文献进行了检索。检索到 1121 项研究,根据标题或摘要排除了 1080 项,根据文本排除了 26 项。从纳入文献的参考文献中检索到一篇文章,共有 15 篇文章符合纳入标准。本综述使用医学教育研究质量仪器(MERSQI)评估纳入研究的质量。利用 4 个关键结果进行分析,并为未来的教育和/或研究提出建议。建议根据推荐等级分类(SORT)进行分级。
本综述一致发现,癌症患者、照护者和肿瘤学专业医疗人员从具有药理活性的 CAM 教育中受益,并建议为这一人群提供此类教育。然而,综述发现,许多教育形式被使用,并且对于最成功的方法没有共识。
未来的研究应该研究 CAM 教育应该针对哪些人群,哪种交付平台最容易获得和有用,以及哪些教育内容最能提高 CAM 知识。CAM 在癌症患者中的普及以及它们的使用所带来的潜在危险需要进一步研究如何向这一人群传达 CAM。